GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 2 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,894,000 | -60.8% | 571,115 | -81.6% | 0.01% | -53.8% |
| Q2 2022 | $99,262,000 | -9.9% | 3,106,801 | -2.3% | 0.01% | +18.2% |
| Q1 2022 | $110,200,000 | +15.5% | 3,181,299 | -2.4% | 0.01% | +22.2% |
| Q4 2021 | $95,440,000 | +9.9% | 3,260,685 | -4.3% | 0.01% | +12.5% |
| Q3 2021 | $86,836,000 | -34.1% | 3,407,994 | -9.4% | 0.01% | -33.3% |
| Q2 2021 | $131,682,000 | -16.6% | 3,760,195 | -2.9% | 0.01% | -25.0% |
| Q1 2021 | $157,868,000 | -10.3% | 3,874,066 | -4.7% | 0.02% | -11.1% |
| Q4 2020 | $175,974,000 | -24.2% | 4,063,123 | -3.5% | 0.02% | -33.3% |
| Q3 2020 | $232,092,000 | -19.4% | 4,209,134 | -7.7% | 0.03% | -25.0% |
| Q2 2020 | $287,901,000 | +11.5% | 4,560,443 | -9.7% | 0.04% | -12.2% |
| Q1 2020 | $258,136,000 | -42.6% | 5,052,582 | -10.7% | 0.04% | -29.3% |
| Q4 2019 | $449,610,000 | +102.4% | 5,656,185 | +23.5% | 0.06% | +87.1% |
| Q3 2019 | $222,174,000 | +1.1% | 4,579,025 | +9.6% | 0.03% | 0.0% |
| Q2 2019 | $219,707,000 | +15.2% | 4,176,942 | +15.9% | 0.03% | +10.7% |
| Q1 2019 | $190,767,000 | +47.9% | 3,604,134 | +14.7% | 0.03% | +27.3% |
| Q4 2018 | $129,002,000 | +13.6% | 3,142,546 | +5.2% | 0.02% | +29.4% |
| Q3 2018 | $113,544,000 | -8.6% | 2,988,007 | +8.7% | 0.02% | -10.5% |
| Q2 2018 | $124,191,000 | +1.5% | 2,747,597 | +8.5% | 0.02% | 0.0% |
| Q1 2018 | $122,358,000 | +61.0% | 2,533,289 | +31.2% | 0.02% | +58.3% |
| Q4 2017 | $76,007,000 | +266.7% | 1,931,562 | +189.4% | 0.01% | +200.0% |
| Q3 2017 | $20,727,000 | +36.3% | 667,549 | +20.1% | 0.00% | +33.3% |
| Q2 2017 | $15,202,000 | +207.1% | 555,826 | +62.3% | 0.00% | +200.0% |
| Q4 2016 | $4,950,000 | – | 342,573 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |